66 related articles for article (PubMed ID: 23042095)
21. Clinical validity of saliva and novel technology for cancer detection.
Kaczor-Urbanowicz KE; Wei F; Rao SL; Kim J; Shin H; Cheng J; Tu M; Wong DTW; Kim Y
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):49-59. PubMed ID: 31152821
[TBL] [Abstract][Full Text] [Related]
22. Promoter Hypermethylation of Tumor-Suppressor Genes
Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
[TBL] [Abstract][Full Text] [Related]
23. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma.
Meng W; Cui W; Zhao L; Chi W; Cao H; Wang B
J Biomed Sci; 2019 Jan; 26(1):13. PubMed ID: 30684967
[TBL] [Abstract][Full Text] [Related]
24. Epigenetics of oral and oropharyngeal cancers.
Russo D; Merolla F; Varricchio S; Salzano G; Zarrilli G; Mascolo M; Strazzullo V; Di Crescenzo RM; Celetti A; Ilardi G
Biomed Rep; 2018 Oct; 9(4):275-283. PubMed ID: 30233779
[TBL] [Abstract][Full Text] [Related]
25. Clinical and Molecular Characterization of Surgically Treated Oropharynx Squamous Cell Carcinoma Samples.
de Carvalho AC; Melendez ME; da Silva Sabato C; Palmero EI; Arantes LMRB; Neto CS; Carvalho AL
Pathol Oncol Res; 2019 Jul; 25(3):1047-1058. PubMed ID: 30099696
[TBL] [Abstract][Full Text] [Related]
26. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.
Winer A; Adams S; Mignatti P
Mol Cancer Ther; 2018 Jun; 17(6):1147-1155. PubMed ID: 29735645
[TBL] [Abstract][Full Text] [Related]
27. Non-blood circulating tumor DNA detection in cancer.
Peng M; Chen C; Hulbert A; Brock MV; Yu F
Oncotarget; 2017 Sep; 8(40):69162-69173. PubMed ID: 28978187
[TBL] [Abstract][Full Text] [Related]
28. Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer.
Yokoi K; Yamashita K; Watanabe M
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28358330
[TBL] [Abstract][Full Text] [Related]
29. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
[TBL] [Abstract][Full Text] [Related]
30. TIMPs: versatile extracellular regulators in cancer.
Jackson HW; Defamie V; Waterhouse P; Khokha R
Nat Rev Cancer; 2017 Jan; 17(1):38-53. PubMed ID: 27932800
[TBL] [Abstract][Full Text] [Related]
31. Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers.
Lim Y; Wan Y; Vagenas D; Ovchinnikov DA; Perry CF; Davis MJ; Punyadeera C
BMC Cancer; 2016 Sep; 16(1):749. PubMed ID: 27663357
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of epigenetic alterations in head and neck squamous cell carcinoma.
Koffler J; Sharma S; Hess J
Mol Cell Oncol; 2014; 1(2):e954827. PubMed ID: 27308324
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
34. Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma.
Szyfter K; Wierzbicka M; Hunt JL; Rinaldo A; Rodrigo JP; Takes RP; Ferlito A
Eur Arch Otorhinolaryngol; 2016 Mar; 273(3):537-45. PubMed ID: 25355032
[TBL] [Abstract][Full Text] [Related]
35. Novel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinoma.
Langevin SM; Butler RA; Eliot M; Pawlita M; Maccani JZ; McClean MD; Kelsey KT
Oral Oncol; 2014 Nov; 50(11):1072-80. PubMed ID: 25242135
[TBL] [Abstract][Full Text] [Related]
36. TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors.
Rettori MM; de Carvalho AC; Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
J Transl Med; 2013 Dec; 11():316. PubMed ID: 24359512
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
[TBL] [Abstract][Full Text] [Related]
38. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.
Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA
Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635
[TBL] [Abstract][Full Text] [Related]
39. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
40. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
